Provectus Biopharmaceuticals Inc (PVCT)

[vorlon1966]

Ok...I see your point. If you go back and look.....they typically spend almost as much every quarter. Getting PIII ready, liver sites ready, CRO's.....it adds up. But....the average cost of getting a drug to market runs between one and five billion.

http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/

Now if you factor that 70% of the cost of testing is in PIII then one could expect to spend at least 700 million for PIII. However, PVCT expects to spend less than 20 million over two years. I don't see the problem.